Results 221 to 230 of about 142,779 (351)

Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Obesity is an increasingly prevalent, chronic, heterogeneous disease, associated with a variety of obesity‐related complications (ORCs). This systematic literature review assessed US healthcare resource utilisation (HCRU) and costs (direct and indirect) for people living with obesity (PwO) or overweight and ORCs.
Jaime P. Almandoz, Jamy D. Ard, Chellse Gazda, Shenelle Edwards‐Hampton   +3 more
wiley   +1 more source

The outcomes of pregnancy after metabolic and bariatric surgery: a literature review. [PDF]

Arch Gynecol Obstet
Keshtkaran P, Hashemi A, Razeghi M, Moosaie M, Alamdarloo SM.   +4 more
europepmc   +1 more source

Experiences of food and relationships after bariatric surgery : an interpretative phenomenological analysis

, 2014
Stephen David Hoole
openalex   +1 more source

MVNGM5YG7Q The Impact of Ursodiol Use on Hospital Admissions and Operations for Gallstone Disease up to 5 Years Following Bariatric Surgery: A Statewide Analysis

openalex   +2 more sources

Clinical science and care incorporating the development of a European Platform for Clinical Research in Diabetes (EPCRD) [PDF]

, 2010
Danne, T., Diamant, M., Hood, G., Kautzky-Willer, A., Kerr, David, Mitrakou, A., Nilsson, P.A., Nolan, J. J, Pacini, G.   +8 more
core  

Acarbose or Canagliflozin vs. Placebo to Ameliorate Post‐Bariatric Hypoglycaemia: The Clinical Outcomes of the HypoBar I Randomised Clinical Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Treatment options for post‐bariatric hypoglycaemia (PBH) are empirical. We aimed to investigate the efficacy and safety of acarbose and canagliflozin for the treatment of PBH. Materials and Methods We performed a randomised, double‐blinded, cross‐over, placebo‐controlled clinical trial where placebo, acarbose 50 mg thrice daily, and ...
Carolina B. Lobato, Clara Tornøe Winding, Kirstine N. Bojsen‐Møller, Bolette Hartmann, Christoffer Martinussen, Simon Veedfald, Jens J. Holst, Sten Madsbad, Nils Bruun Jørgensen, Carsten Dirksen   +9 more
wiley   +1 more source

Assessing the Impact of Bariatric Surgery on Quality of Life in the Saudi Population: A Systematic Review. [PDF]

Diabetes Metab Syndr Obes
Alqhtani H.
europepmc   +1 more source

Primary endoscopic interventions in bariatric surgery [PDF]

Chibueze A. Nwaiwu, Errol M. Hunte, Marcoandrea Giorgi, Aurora D. Pryor   +3 more
openalex   +1 more source

Could the mechanisms of bariatric surgery hold the key for novel therapies?: report from a Pennington Scientific Symposium [PDF]

, 2011
Charmaine S. Tam, Hans‐Rudolf Berthoud, Marco Bueter, Manu V. Chakravarthy, Allan Geliebter, A. Hajnal, Jens J. Holst, Lee M. Kaplan, Walter J. Pories, Helen E. Raybould, Randy J. Seeley, April D. Strader, Éric Ravussin   +12 more
openalex   +1 more source

Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction‐Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta‐Analysis of Randomised Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is closely linked to obesity and insulin resistance, and sustained weight loss is associated with histological improvement. Whether different obesity‐management modalities exert weight‐independent hepatic effects remains uncertain.
Matteo Monami, Amanda Belluzzi, Silvio Buscemi, Luca Busetto, Ricardo Cohen, Maurizio De Luca, Andrea Galli, Edoardo Mannucci, Tarissa Z. Petry, Benedetta Ragghianti, Paolo Sbraccia, Dror Dicker   +11 more
wiley   +1 more source